Comparison of AV Optimization Methods Used in Cardiac Resynchronization Therapy (CRT)

PHASE4CompletedINTERVENTIONAL
Enrollment

1,060

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Heart Failure
Interventions
DEVICE

AV Delay programming through cardiac resynchronization therapy

"All subjects in this trial receive the same device. For the purpose of this trial. intervention is programming of the atrio-ventricular (AV) delay in the two treatment arms, while the control arm will receive AV delay programming from a Fixed nominal setting. Echo optimized and Algorithm optimized are the treatment arms programmed to receive optimized AV delay settings and will be compared to the Fixed nominal arm."

DEVICE

AV Delay programming through cardiac resynchronization therapy

"All subjects in this trial receive the same device. For the purpose of this trial. intervention is programming of the atrio-ventricular (AV) delay in the two treatment arms, while the control arm will receive AV delay programming from a Fixed nominal setting. Echo optimized and Algorithm optimized are the treatment arms programmed to receive optimized AV delay settings and will be compared to the Fixed nominal arm."

DEVICE

AV Delay programming through cardiac resynchronization therapy

"All subjects in this trial receive the same device. For the purpose of this trial. intervention is programming of the atrio-ventricular (AV) delay in the two treatment arms, while the control arm will receive AV delay programming from a Fixed nominal setting. Echo optimized and Algorithm optimized are the treatment arms programmed to receive optimized AV delay settings and will be compared to the Fixed nominal arm."

Trial Locations (1)

23298-0053

Medical College of Virginia, Richmond

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT00677014 - Comparison of AV Optimization Methods Used in Cardiac Resynchronization Therapy (CRT) | Biotech Hunter | Biotech Hunter